Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-12-009675
Filing Date
2012-06-05
Accepted
2012-06-05 18:32:41
Documents
1
Period of Report
2012-06-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 5696
  Complete submission text file 0001179110-12-009675.txt   7177
Mailing Address C/O AMGEN INC ONE AMGEN CENTER DR THOUSAND OAKS CA 91320-1799
Business Address
WILLIAMS DOUGLAS E (Reporting) CIK: 0001184847 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33882 | Film No.: 12890373

Mailing Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121
Business Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121 (206) 801-2100
Oncothyreon Inc. (Issuer) CIK: 0001412067 (see all company filings)

EIN.: 260868560 | State of Incorp.: DE | Fiscal Year End: 0612
SIC: 8731 Services-Commercial Physical & Biological Research